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2 
Abstract 
Ca
2+
 is the key intracellular regulator of insulin secretion, acting in the beta cell as the ultimate trigger 
for exocytosis. In response to high glucose, ATP-sensitive K+ channel closure and plasma membrane 
depolarisation engage a sophisticated machinery to drive pulsatile cytosolic Ca2+ changes. Voltage-
gated Ca
2+
 channels, Ca
2+
-activated K
+
 channels and Na
+
/Ca
2+
 exchange all play important roles. The 
use of targeted Ca
2+
 probes has revealed that during each cytosolic Ca
2+ 
pulse, uptake of Ca
2+
 by 
mitochondria, endoplasmic reticulum (ER), secretory granules and lysosomes fine-tune cytosolic Ca2+ 
dynamics and control organellar function. For example, changes in the expression of the Ca2+ binding 
protein Sorcin appear to provide a link between ER Ca
2+ 
levels and ER stress, affecting beta cell 
function and survival. Across the islet, intercellular communication between highly interconnected 
“hubs”, which act as pacemaker beta cells, and subservient “followers”, ensures efficient insulin 
secretion. Loss of connectivity is seen after the deletion of genes associated with type 2 diabetes 
(T2D) and follows metabolic and inflammatory insults that characterize this disease. Hubs, which 
typically comprise ~1-10 % of total beta cells, are repurposed for their specialized role by expression 
of high glucokinase (Gck) but lower Pdx1 and Nkx6.1 levels. Single cell -omics are poised to provide 
a deeper understanding of the nature of these cells and of the networks through which they 
communicate.  New insights into the control of both the intra- and intercellular Ca
2+
 dynamics may 
thus shed light on T2D pathology and provide novel opportunities for therapy.  
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3 
Introduction 
A likely role for Ca
2+
 in the control of insulin secretion was first shown by experiments 
demonstrating that the release of the hormone in response to fuel secretagogues was blocked in the 
absence of these ions [1] (and references therein). A role for Ca2+ as a cardinal trigger for secretion 
was later enshrined in the “consensus” model of glucose-induced insulin secretion, which involves 
activation of glycolytic and mitochondrial ATP synthesis, closure of ATP-sensitive K
+
 channels 
(KATP), plasma membrane depolarisation and Ca
2+ influx through voltage-dependent Ca2+ channels 
(VDCC) [2] (Fig. 1). The contributions of intracellular Ca2+ transport pathways, and of other 
intracellular ion channels, in the generation of these signals remains more controversial, and will be 
discussed later.  
Our focus in this contribution will thus be the role and regulation of Ca2+ dynamics in and 
between beta cells. For a more comprehensive review of the role of these ions in the regulation of 
secretion from other islet neuroendocrine cells, the reader is referred to recent articles, e.g. [3,4].  
Key technical developments in Ca2+ signalling 
A full appreciation of the control and likely importance of glucose-triggered intracellular Ca2+ 
changes in beta cells was significantly enhanced by the development by Tsien and colleagues [5] of 
chemically-synthesized, low molecular weight and intracellularly-trappable dyes such quin-2 [6] and 
later fura-2 [7-9]. These optical probes allowed fluctuations in free Ca2+ to be reported in real time in 
single living cells and, subsequently, at the subcellular level, though fluorescence imaging. This 
technique thus allowed the elaboration of earlier biochemical studies, based on the use of 
radioisotopes such as 
45
Ca, and revealed, for example, the importance of Na
+
/Ca
2+
 exchange in Ca
2+
 
extrusion [10], as well as regionalisation of Ca2+ responses to glucose and other stimuli [8].  
A limitation of the above class of probes is, however, that they do not usually allow Ca2+ to be 
measured selectively in subcellular organelles. This restricts studies aimed at understanding the 
molecular mechanisms (transporters, channels etc) which mediate Ca2+ flux across the relevant 
membranes. Alternative probes, developed shortly after the fluorescent reporters, by Pozzan and 
Rizzuto [11], and deployed by us and others in beta cells [9,12,13], exploited instead natural 
bioluminescent sensors, such as aequorin from the jellyfish Aequoria victoria. Whilst in earlier studies 
these proteins had been purified and introduced directly into cells, for example after skinning of 
muscle fibres [14], the development of recombinant technologies meant they could be expressed from 
the corresponding cDNA. Importantly, after fusion of these cDNAs with those encoding suitable 
targeting sequences, the bioluminescent probes could be targeted directly to selected subcellular 
locations. The targeting domains usually involved short peptide sequences or, in some cases, a full 
length protein [13,15]. Transfection with the corresponding plasmids (or expression from viral 
constructs), and reconstitution with the prosthetic group coelenterazine, was then coupled to suitable 
(and usually highly sensitive) detection systems: a simple photomultiplier tube usually sufficed [16], 
though subsequent developments used in-sequence photocathode arrays for imaging [17].  
The first chimaeric probe to be used in this way in beta cells was an aequorin, linked to the 
leader sequence of mitochondrial cytochrome c oxidase subunit VIII [18], thus localising it to the 
mitochondrial matrix [9]. Probes targeted to the endoplasmic reticulum (ER) and Golgi [19], as well 
as secretory granules [19], were subsequently deployed, and will be discussed in more detail below. 
Although later superseded by more sensitive fluorescent recombinant probes based on green 
fluorescent protein (GFP) [3,20], much of our current knowledge of organellar Ca
2+
 dynamics in beta 
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4 
cells was based on the use of the above. GFP-based probes, in contrast, rely on Ca2+-induced changes 
either in the intrinsic fluorescence of the GFP backbone (created by the introduction of a Ca
2+
 sensing 
domain onto a circularly-permuted fluorophore) or the Ca
2+
-dependent change on the interaction 
between two spectrally-shifted GFP variants (Förster resonance energy transfer; FRET), again 
controlled by Ca
2+
 binding to peptide linking the pair. Table 1 provides a list of chemical and 
recombinant Ca
2+ 
probes and examples of their use in beta cells (or other tissue where information is 
not available).  
The following section summarises the key findings made using the above targeted probes in 
beta cells. These are summarized in Figure 1.  
Localisation of glucose-induced Ca
2+
 changes in beta cells 
Cytoplasmic Ca2+ levels in beta cells are maintained via a complex interplay between Ca2+ 
entry (predominantly through VDCC), Ca2+ uptake and release from/into intracellular stores, 
organelles and secretory granules, and Ca
2+
 extrusion via plasma membrane pumps (e.g. Ca
2+
 
ATPase) and exchangers (e.g. Na+/Ca2+ exchanger). Alteration at any point in this regulatory cascade 
– either as a result of changes in energy metabolism and hence KATP channel closure, or in the 
expression or post-translational modification of Ca
2+
 channels/pumps/exchangers – will lead to 
alterations in beta cell Ca
2+
 concentration, with knock-on effects for insulin release.  
Mitochondria: Mitochondrial metabolism is critical for glucose-induced insulin secretion 
[21]. Correspondingly, alternative fates for glycolytically-generated pyruvate catalysed by lactate 
dehydrogenase (LDHA) and the plasma membrane lactate / pyruvate transporter SLC16A1 (MCT1) 
are selectively suppressed, or “disallowed”, in the beta cell, i.e. these activities are present at 
unusually low levels in beta cells compared to all other tissues [22]. 
Although long considered to serve chiefly as buffers and reservoirs of Ca2+ in mammalian 
cells, mitochondria were ultimately recognised as the targets of cytosolic Ca
2+
 increases, whose 
oxidative metabolism is subject to control by these ions, as a result of work in the 1970s and 1980s by 
Denton, McCormack and Halestrap [23]. Three NAD+-linked intramitochondrial enzymes, pyruvate 
(PDH), NAD
+
-isocitrate (ICDH) and 2-oxoglutarate (OGDH) dehydrogenase are strongly stimulated 
by Ca
2+
, either through the activation of the associated protein phosphate phosphatase (PDH) or 
through direct binding and allosteric regulation [24,25]. Other enzymes involved in mitochondrial 
oxidative metabolism, including the aspartate-glutamate exchanger Aralar (Slc25a12), implicated in 
the control of beta cell glucose metabolism [26], respiratory chain complexes and the mitochondrial 
F1Fo ATP synthase [27], as well as the adenine nucleotide translocase (ANT) (which, as a complex 
with the phosphate carrier, may create the “mitochondrial permeability transition pore” (PTP), 
associated with cell death) [28], are also subject to regulation by Ca2+ (Fig. 2). Finally, glycerol 
phosphate dehydrogenase (GPDH) [29] is also subject to control by Ca
2+
, though in this case Ca
2+
 
binding is thought to occur on the cytosolic face of the inner mitochondrial membrane. Additionally, 
mitochondria are the source of putative coupling factors such as glutamate [30,31] which may 
contribute to the “KATP channel-independent” actions of glucose on insulin secretion [32]. The 
regulation of the production of these factors by Ca
2+ 
is presently not well understood. Of note, 
glucagon-like peptide-1 (GLP-1), which appears to engage this pathway through increases in 
intracellular cAMP and activation of Exchange protein directly activated by cyclase 2 (Epac2, 
Rapgef4) [33,34] was also found to increase ATP/ADP levels in beta cells in our hands [35,36] 
though not in others’ [37]. 
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5 
As observed in extrapancreatic cells [18], increases in mitochondrial free Ca2+ (from <100 nM 
to 1-20 µM), which exceed those observed in the cytosol (~100 nM to ~500 nM), are apparent upon 
stimulation of clonal beta cells [9,12] by high glucose or KCl-induced depolarisation. We [38] and 
others [39] have subsequently argued, in line with the “Denton hypothesis” (above), that 
mitochondrial Ca
2+
 increases following those in the cytosol provide a further stimulus (feed-forward) 
for ATP synthesis,  
 
 
 
thus ensuring an amplification of the glucose-induced increase in ATP synthesis for a given increase 
in extracellular glucose. Direct imaging of ATP/ADP increases with the recombinant sensor Perceval 
[38] provided further evidence for this view. Moreover, silencing of the mitochondrial calcium 
uniporter MCUa [40] led to a blockade of the second phase of ATP/ADP increase in beta cells. 
Likewise, expression of the Ca
2+
 binding protein S100G, molecularly-targeted to the mitochondrial 
matrix, blocked glucose-induced NAD(P)H and ATP/ADP increases and reduced the second phase of 
glucose-stimulated insulin secretion [41]. Conversely, silencing of the mitochondrial Ca
2+
/Na
+
 
exchanger NCLX delayed glucose-induced insulin secretion [42]. At present, a demonstration of the 
impact of genetic inactivation of MCUa in the beta cell in mice is still awaited. Interestingly, 
mitochondrial Ca2+ and ATP/ADP increases display a stronger dependence on the frequency of 
cytosolic Ca
2+ 
spikes, rather than their amplitude, indicating
 
that the mitochondrial Ca
2+ 
uptake 
systems
 
provides a means of achieving “frequency modulation” of the biological response [43].  
Challenging the above view, it has been suggested [44] that, since increases in mitochondrial 
NAD(P)H are not observed when Ca2+ increases are imposed through cellular depolarisation alone 
(i.e. in the absence of glucose), these ions do not stimulate mitochondrial ATP synthesis. Tengholm 
and colleagues [45] have similarly proposed that, as cytosolic ATP/ADP levels fell upon stimulation 
of Ca2+ influx and rose when the latter was blocked, Ca2+ per force is an inhibitor of mitochondrial 
ATP synthesis. Drews et al [44] have also argued that activation of mitochondrial ATP synthesis 
would tend to oppose the well-known bursting activity of the beta cell, and associated Ca
2+
 
oscillations, by leading to further closure of KATP channels between bursts. It should be emphasised 
that non-perturbing experiments of the sort presented by Drews and colleagues are difficult to 
interpret, measuring as they do steady state levels of intermediates, rather than changes in flux: 
coincident activation of ATP consumption in the cytosol by Ca
2+
 (e.g. for ion pumping, protein 
synthesis) may thus drive the ADP re-oxidation of NAD(P)H by the respiratory chain. Of note, 
modelling studies [46] have demonstrated that Ca2+ activation of PDH is required in to provide an 
adequate fit to experimental observations of oscillatory activity in glycolytic flux and cytosolic Ca
2+
. 
Although early studies revealed heterogeneity in ATP levels between islet regions 
corresponding to a few cells (resolution in this case being limited by the relatively weak photon 
production by firefly luciferase, used in these studies) [47], others have shown this not to be the case 
using different approaches (i.e. NADH/NADPH imaging) [48], highlighting possible divergence 
between NADH/NADPH and ATP/ADP fluxes.   
Secretory pathway. Ca2+ is present at very high levels in the granule lumen, largely bound to 
insulin hexamers with Zn
2+
. Total concentrations of Ca
2+
 are thus ~120 mM in this compartment [49]. 
By contrast, measurements of intragranular Ca
2+
 achieved using a chimeric Ca
2+
 sensor generated by 
…..mitochondrial Ca2+ increases 
following those in the cytosol 
provide a further stimulus (feed-
forward) for ATP synthesis….. 
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6 
the fusion of vesicle-associated membrane protein-2 (VAMP2) and aequorin, indicated free Ca2+ 
levels in secretory granules in the ~40 µM range [50]. Importantly, a fraction of the intragranular pool 
may be mobilized in response to a glucose-generated increase in intracellular nicotinic acid adenine 
dinucleotide phosphate (NAADP). Whether this, or a lysosomal [51] pool, is then responsible for two 
pore channel 2 (TPC2) -dependent and localised Ca
2+ 
changes which may control plasma membrane 
potential (by regulating flux through a non-selective cation channel, possibly TRPM4 or TRPM5) is 
still under investigation. Of note, TPC2 (Tpcn2) deletion from the beta cell in mice had no effect on 
insulin secretion or glucose homeostasis in vivo [52], possibly as a result of compensation by TPC1 
(Tpcn1); simultaneous inactivation of both channels in the beta cell will be needed to test this 
hypothesis. Interestingly, highly localised depolarisation-induced Ca
2+
 changes were also apparent at 
the secretory granule surface [53] and may play a role in catalysing exocytosis though interaction with 
plasma membrane located channels, as described above, or critical soluble N-ethylmaleimide sensitive 
factor attachment protein (SNAP) and SNAP receptor (SNARE) proteins (e.g. Synpatotagmin 7) [54] 
located on the granule itself. 
Endoplasmic reticulum: The chief systems through which Ca2+ is accumulated by and 
released from the ER are shown in Fig. 1. The ER is an important site for Ca
2+
 clearance, with 
modelling studies showing that sarco(endo-)plasmic reticulum Ca
2+
-ATPase (SERCA) activity 
accounts for ~ 60% of Ca2+ removal [55]. Although proposed in one study to cause a decrease in ER 
Ca2+ due to the activation of Ca2+-induced Ca2+ release (CICR) [56], subsequent work [20], using a 
fluorescent probe (the “cameleon”, Ycam-4ER) carefully checked for pH-induced artefacts, as well as 
studies using a targeted aequroin [12], revealed increases in this compartment following stimulated 
Ca2+ influx in response to depolarisation provoked artificially with K+ ions, or glucose. It is, of course, 
difficult to exclude the possibility that CICR, although outweighed by Ca2+ uptake to give net Ca2+ 
accumulation, does not play a role to limit the latter. In this context, the role of ryanodine receptors in 
beta cells has been a source of controversy [57]; the most recent and sensitive RNAseq-based studies 
have, however, revealed low but detectable levels of expression (at the mRNA level) of this family in 
beta cells from both mice [58] and man [59], with RyR3 and RyR2 being present, respectively, in 
islets from these species. 
It should also be emphasised that, whilst mobilisation of intracellular stores probably plays 
only a minor role in beta cell responses to glucose, the response to Gq-coupled receptors, e.g. 
metabotropic glutamate receptors and muscarinic agonists, certainly involves the generation of 
inositol 1,4,5-trisphoshate (IP3) and the opening of ER-located IP3 receptor channels, which leads to 
Ca2+ release [6]. The role of local domains of Ca2+ released in this way, and known to be important for 
the stimulation of mitochondrial metabolism in other (non-excitable) cell types, appears to be less 
important in beta cells [3].  
Interestingly, ER Ca2+ depletion, causing ER stress, is associated with beta cell failure and 
T2D risk [60]. As recently reported [61], the Ca2+ binding protein sorcin forms a link between beta 
cell lipotoxicity and ER Ca
2+
 stores. Sorcin (also called SRI) is a 22 kDa member of the penta-EF-
hand family of Ca
2+
-binding proteins. In the presence of elevated Ca
2+
, sorcin undergoes a 
conformational change that triggers its reversible translocation from the cytoplasm to membranes 
where it interacts with specific target proteins, including RyR, which are subsequently inhibited (Fig. 
1).  Mice over-expressing sorcin selectively in the pancreatic beta cell are resistant to diet-induced 
failure of insulin secretion and glucose intolerance [61].  
 
This protection is associated with preserved ER Ca2+ stores and a lowering of glucose 6-
phosphatase C2 (G6PC2) expression. Moreover, sorcin overexpression leads to activation of the 
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7 
unfolded protein response (UPR) sensor activating transcription factor 6 (ATF6), suggesting that the 
latter protein may be involved in the protective actions of this protein. Approaches which increase the 
expression or activity of sorcin may thus provide a means of slowing or preventing beta cell 
deterioration in T2D (Fig. 3). 
 
 
 
 
 
 
Plasma membrane: While their contribution compared to the ER is small, membrane 
exchangers and pumps still play an important role in Ca2+ homeostasis in the beta cell. Recent studies 
have shown that inhibition of the sodium-calcium exchanger isoform 1 (NCX1) results in glucose-
dependent increases in cytosolic Ca2+ concentration and insulin secretion [62]. Similarly, 
heterozygous inactivation of the plasma membrane Ca2+ ATPase (PMCA) leads to intracellular Ca2+ 
accumulation, augmented insulin release and, strikingly, improved beta cell proliferation, viability and 
mass [63].  
Beta cell-beta cell communication: intra-islet connectivity  
It has been known for many years that intercellular communication is important for normal 
insulin secretion. Indeed, early studies noted the presence of a right-shifted glucose concentration-
response curve, lowered insulin gene expression and impaired insulin release in dissociated cells 
versus their counterparts residing within the islet setting [64,65]. This is likely due to loss of cell-cell 
coupling, since seminal studies where the predominant gap junction protein connexin 36 was deleted 
from beta cells showed perturbed population responses to glucose and impaired insulin pulsatility in 
vivo [66]. More recently, ephrins, cilia and paracrine factors (e.g. between alpha and delta -> beta 
cells) have all been shown to contribute to the intra-islet regulation of insulin secretion [67,68].  
 Critical to the study of islet wide Ca
2+
 dynamics has been the development of high speed Ca
2+
 
imaging as a means of providing further evidence for cell-cell communication across the beta cell 
population. Combined with modelling approaches, this has provided a remarkable level of detail 
regarding the role of functional beta cell subpopulations in orchestrating insulin secretion. Evidence 
for “pacemaker” cells within the islet was first obtained in the early 1990s [69]. Subsequently, work 
from Benninger, Piston and colleagues, who pioneered the application of fast multicellular Ca
2+
 
imaging approaches to islets, showed the presence of distinct phase lags between beta cells located 
within different islet regions [70], building on earlier observations using patch clamp 
electrophysiology [71,72]. Demonstrating that the organisation of beta cell activity was more complex 
than originally envisaged, studies using network theory to decode islet-wide Ca
2+
 signals in tissue 
slices revealed a nodal topology where a minority of cells host the majority of functional connections 
in terms of coordinated Ca
2+
 rises [73]. Using analogous techniques, it was shown that a small 
subpopulation of beta cells was responsible for routing information between cells through the islet.  
 
 
 
…..a small subpopulation of beta 
cells was responsible for routing 
information between cells through 
the islet.. 
Mice over-expressing sorcin 
selectively in the pancreatic beta cell 
are resistant to diet-induced failure 
of insulin secretion…. 
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8 
 
These specialised cells, termed “hubs”, were shown to be genuine pacemakers in situ in islets 
by Johnston et al [74] (Fig. 4). Here, we combined online analyses with optogenetics to map the beta 
cell population, allowing hubs to be identified and silenced with pinpoint precision using a 
diffraction-limited laser spot. Parallel experiments were performed to activate the same subpopulation 
using the light-activated sulfonylurea, JB253 [75,76]. Thus, inactivation of the best-connected hubs - 
similar to the previously described nodes [73] - led to a near complete, but readily reversible, 
blockade of Ca2+ dynamics. Conversely, reactivation of hubs (at a sub-stimulatory glucose 
concentration) led, on average, to re-connection to previously-identified follower cells. Using a cell 
surface-tethered Zn
2+
 probe, which measures Zn
2+
 released from the insulin hexamer [77], silencing of 
hubs but not followers decreased insulin secretion, demonstrating the fundamental importance of Ca2+ 
dynamics for islet output. Notably, the hubs were targeted by cytokines to induce islet failure, 
probably due to their lowered expression of the sarco(endo) plasmic reticulum Ca
2+
 ATPase SERCA2 
and susceptibility to ER stress (see later).  
In a similar manner, we [78] were able to show that beta cell-beta cell contacts also existed in 
human islets, although coordinated activity seemed to be driven more strongly by incretin compared 
to glucose, the latter secretagogue instead engaging communication between local clusters [79]. 
Importantly, this connectivity was disrupted by glucolipotoxic insults in vitro, and we were able to 
infer, through a strong negative correlation with body mass index, a likely association with insulin 
resistance in man [78]. It should be emphasized that, although we have reported that incretin-
enhanced connectivity [78] was unaffected by aging (in contrast to a strong inverse relationship with 
body mass index), changes in glucose-dependent connectivity have not so far been reported. 
However, alterations in Ca2+ dynamics with age in mice raise the possibility that connectivity may 
also be targeted [80].  
Further supporting a critical role of connectivity in human islets were studies in which the 
genome-wide identified T2D-associated genes T-cell factor-7-like 2 (TCF7L2) [81] and Adenylate 
cyclase 5 (ADCY5) [82] were deleted in rodent islets or silenced in human beta cells, respectively, 
leading to weakening of local coordination in response to glucose and impaired insulin secretion. 
Interestingly, deletion of other T2D-associated genes, SLC30A8 (ZnT8) [83] or STARD10 (G.A.R. 
and P.C., unpublished), from mouse islets, had no impact on Ca2+ dynamics or intercellular 
connectivity.  Nonetheless, these findings demonstrate the potential for inheritance of altered Ca
2+
 
responses as a factor affecting T2D risk. 
Transcriptional control of Ca2+ dynamics and modifications in T2D 
 The regulation of Ca2+ channels and other players in Ca2+ dynamics is still not well 
understood although the dysregulation of several of these is hinted by studies of islets from T2D 
versus control subjects. Thus, analysis of the data from Fadista and colleagues [84] reveals a Gene 
Ontology (GO) group “Regulation of calcium ion transport” as affected with marginal significance 
(p=0.07). Future studies with larger numbers of subjects will be needed to confirm or refute this 
finding. Consistent with these observations, recent studies in rodents from Speier and colleagues [85] 
have shown a gradual degradation of normal glucose-induced islet Ca2+ dynamics in islets 
transplanted into the anterior chamber of the eye, and exposure of the recipients to a diabetogenic diet, 
compared to animals maintained on a normal diet. Whether similar changes are observed during the 
course of prediabetes and diabetes in man remains to be ascertained.  
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9 
It should be noted in this context that there is increasing (though contested) evidence that a 
loss of beta cell “identity” – involving a loss of expression of beta cell signature genes and the 
reactivation of “disallowed” genes and genes usually expressed only in beta cell progenitors - 
contributes to cellular dysfunction in T2D [86]. Of note, two key transcription factors responsible for 
the establishment and maintenance of beta cell identity, regulatory factor X6 (RFX6) [87] and paired 
box 6 (PAX6) [88], regulate the expression of multiple Ca
2+
 channels, as revealed by targeted 
inactivation of these factors in the adult mouse beta cell, leading to reduced cytoplasmic Ca2+ fluxes. 
RFX6 has recently been shown to be a new Maturity Onset Diabetes of the Young (MODY) gene by 
Hattersley and colleagues (http://biorxiv.org/content/early/2017/01/22/101881), suggestive of a 
possible role for these changes in monogenic diabetes. Moreover, Ca
2+
 channels constitute a Gene 
Ontology group identified as selectively changing in Pax6 null islets [88]. Thus, expression of 
proteins critical for normal Ca2+ homeostasis and signalling is a feature of the mature, differentiated 
beta cell, and may be altered in T2D to affect beta cell responses to glucose.  
Interestingly, recent studies (Mitchell et al, under revision) demonstrate that beta cell–beta 
cell connectivity can persist, and even be enhanced, in the face of marked “de-differentiation” of the 
beta cells following deletion of Pax6. This manoeuvre is associated with drastic decreases in the 
expression of other key factors such as Pdx1 and MafA, and a > 60% decrease in insulin levels on a 
per cell basis, and is accompanied by Ca2+ increases of lower amplitude but exaggerated connectivity 
in response to elevated glucose. Intriguingly, levels of Gck are increased, whilst Gcpc2 (which 
opposes the action of Gck) are strongly decreased. These changes are thus remarkably reminiscent of 
the characteristics described for hub cells [74] (and see above), which were shown to possess lowered 
PDX1, NKX6.1 and insulin immunoreactivity, and suggest that a significant proportion of beta cells 
in this model may assume “hub-like” properties favouring glucose metabolism. Nonetheless, overall 
glucose-induced increases in ATP/ADP are impaired across the islet in this model, at odds with the 
more energetic status of hubs, although we note that the latter was assessed using mitochondrial 
membrane potential as a proxy and this may not necessarily reflect ATP synthesis [74]. Formal 
analysis of hub and spoke numbers, or conversely mosaic rescue experiments where some cells are 
forced to be mature, will be required therefore to test the above model in future. A tantalizing prospect 
is that restoration of insulin secretion during T2D, which is associated with frank beta cell de-
differentiation (see above and [86,89]), may benefit more from recreating transcriptional and 
functional heterogeneity rather than uniform maturity. Indeed, recent studies have shown that fasting 
promotes beta cell regeneration through a backwards step via localised expression of Sox17, Pdx1 and 
Ngn3 [90]. 
 
 
 
  
Critical questions around hub cells and connectivity 
Provenance and stability. It remains unclear whether hub cells represent a stable population 
which forms when each islet develops, or a more transient population subject to complex 
transcriptional dynamics such as those shown to exist in other endocrine tissue [91]. Whilst we have 
not observed changes in hub/follower interactions over a period of 2h [74], further developments in 
…restoration of insulin secretion 
during T2D … may benefit more 
from recreating transcriptional and 
functional heterogeneity. 
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10
imaging technology will be necessary to explore the nature of these cells over longer time periods 
(e.g. following the transplantation of islets into the anterior chamber of the eye) [92]. 
Transcriptional identity. A clutch of recent papers [93-95] has provided transcriptomic data 
for single beta and other islet cells from both human and mouse using next generation RNA 
sequencing in single cells (scRNA-seq). Whilst marked heterogeneity was not apparent in rodent 
islets, this was more evident in beta cells from man. Nonetheless, re-analysis of the data provided by 
Xin et al [94] reveals evidence for a sub-population with hub-like properties (i.e. high Gck, low Pdx1 
and low Nkx6.1 expression). This confirms earlier studies by Szabat et al [96], showing the existence 
of an insulin-low, Pdx1-low population using fluorescence-activated cell sorting. A key future goal 
will be to perform similar analyses on bona fide hub cells identified as described in [74], although a 
complicating factor may be transcriptional changes expected to occur following dissociation of cells 
from the tissue environment [97].  
Nature of the connections between network-connected cells. Whilst connections driven by 
inter-islet neurons remain possible, the loss of these during isolation and culture makes this an 
unlikely mechanism. Cilia also represent a possible means of conducting signals and these have been 
shown to contact ~ 25% of the beta cell population [67]. Of note, disruption of the Bbs4 gene in mice 
leads to basal body/primary cillary perturbations [67] and is associated with impaired first phase 
insulin release both in vivo and in isolated islets. 
Proximity to other islet types. An intriguing possibility is that hubs may be located within a 
particular niche, for example in close proximity to blood vessels, to other islet cell types (delta or 
alpha cells?) or to nerve endings. We note here that differences between the innervation of human and 
mouse islets [98] may be of relevance, although even in human islets rare connections are still seen 
between neurons and beta cells [98]. It must be emphasised that the studies reported up to now have 
used cultured islets wherein both interneurons and blood vessels have largely collapsed. Studies are 
therefore underway to investigate these questions, including through imaging islets implanted in the 
anterior eye chamber [92] and directly in the pancreas [99] where neural and vascular supplies are 
rewired or maintained.  
Role of gap junctions. The demonstrated requirement for Cx36 (Gjd2) [74] indicates that gap 
junctions are essential for transmission. Our current strategies have relied on imaging across a layer of 
cells in a single plane, and it is conceivable that out-of-plane connections, involving a “train” of cells 
which transmit signals exists. Alternative imaging modalities, which capture further cell layers, and 
higher rates of image capture, will be important to explore this possibility. Although the highly-
scattering nature of the islet prevents truly deep imaging at cellular resolution, light-sheet approaches 
in relatively opaque zebrafish may provide a useful alternative to investigating 3D Ca2+ dynamics in 
the islets.  
Clinical relevance. Great strides have been made in recent years to develop beta-like cells 
from human embryonic stem (hES) and induced pluripotent stem cells (iPS) [100]. Intriguing 
questions remain as to whether these resemble any of the islet cell types described by our functional 
imaging studies described above [74,78], as well as those defined by Grompe and colleagues [101]. It 
will equally be of interest to know whether “hubbiness” can be recapitulated in the “synthetic” islet-
like organoids generated through these routes in vitro or in vivo. Moreover, whether beta cell re-
programming in vivo properly recapitulates a heterogeneous landscape is unknown, and this may be 
relevant for T2D treatment considering the requirement for subtle cell-cell differences in insulin 
release, as shown by functional and transcriptomic studies.  
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11
Human islet hubs. Although human islets have dissimilar architecture to mouse islets [102], 
cell-cell coordination does occur within local cell clusters [74], as well as globally in response to 
incretin [78]. Whilst we have identified hub cells in human islets, it has not been possible with current 
strategies to prove directly their role as pacemakers for glucose responsiveness due to the inefficient 
expression of halorhodopsin (NpHR) in human beta cells. The use of alternative optogenes alongside 
photopharmacological tools should resolve this question in the future. Likewise, recent developments 
in GLP-1R pharmacology including light-activated incretin-mimetics and GLP-1R positive allosteric 
modulators [103] will help to delineate whether incretin-regulated connectivity is driven by a 
subpopulation of cells, or whether it is the consequence of a more global phenomenon. 
Why are hubs so fragile? An interesting observation is that hubs express low levels of 
SERCA2, a serendipitous finding from attempts to examine ER content (later confirmed to be normal 
using the marker protein disulfide isomerase) [74]. The reason for this is unknown, but may underlie 
the susceptibility of these cells to cytokine insults due to ER stress mechanisms [104]. Conversely, the 
lowered insulin expression found in hubs may offset this vulnerability, since genetically reducing 
insulin output during beta cell compensation to high fat diet has recently been shown to protect 
against ER stress [105].  
 Summary, conclusions and perspectives 
Since the elucidation of its importance as key controller of insulin secretion in the 1970s and 
80s, interest in Ca2+ as a potential target for therapeutic intervention in T2D has remained high. The 
recent description of coordinated Ca
2+
 signals across the islet as vital for normal secretion has further 
emphasized this role. Recent transcriptomic analyses at the single level, and the generation of targeted 
knockouts in mice, will be vital for understanding how these changes occur and perturb normal islet 
function, and in particular affect the interaction between beta cell hubs and followers. The extent to 
which changes in the machinery controlling Ca
2+
 dynamics also acts in other islet cell types to 
influence T2D susceptibility remains a further important area for investigation  
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12
Table 1. Comparison of Ca2+ indicators used in beta cells 
 
Probe Advantages Disadvantages  Example 
Fura 2 • Ratiometric 
• Easy to calibrate 
• Quantitative 
• Large Stokes shift 
• Kd close to resting Ca
2+
 
levels 
• Difficult to load  
 
• UV excitation 
• Dual excitation 
• Complex optical 
setup 
• Difficult to load 
• Medium dynamic 
change 
• Incompatible with 
confocal 
microscopy 
• Can 
compartmentalise 
to organelles 
 
[9] 
Fluo3/4/8 • Very bright 
• Large dynamic range 
• Compatible with most filter 
sets/lasers 
• Compatible with confocal 
microscopy 
• Reduced phototoxicity (as 
laser power can be 
reduced due to 
brightness). 
• Easy to load  
 
• Single wavelength 
• Quantitation 
requires careful 
calibration 
• Small Stokes shift 
 
       [106] 
Rhods/X-
Rhods 
• Red-shifted 
• Allow mitochondrial Ca
2+
 
measures  
• Easy to load  
 
 
• Single wavelength 
• Cytoplasmic Ca
2+
 
measures are 
difficult due to rapid 
mitochondrial 
sequestration  
• Relatively low 
affinity makes 
assessment of 
basal Ca
2+
 difficult 
• Poor dynamic 
range 
 
  [74] 
Fura-Red • Red-shifted 
• Ratiometric 
• Can be used with 
Fluo3/4/8 to allow confocal 
ratiometric imaging 
• Difficult to load  
 
 
• Low quantum yield 
• High 
concentrations 
need to be loaded; 
hence, risk of Ca
2+
 
buffering 
• Very poor dynamic 
range  
[38] 
CaSIRs • Far-red- to NIR-shifted 
• Reduced 
autofluorescence/backgro
und 
• Very large dynamic range 
• Easy to load  
 
• Single wavelength 
• Lysosomal 
accumulation 
• Relatively low 
affinity makes 
assessment of 
basal Ca
2+
 difficult 
[107] 
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13
  
GCamPs • Genetically encoded 
• Can be targeted to cell 
compartments 
• Conditional expression is 
possible in e.g. beta or 
alpha cells 
• Slow, fast and medium 
variants available 
 
• Requires viral 
vectors or mouse 
genetics for 
expression 
• Single wavelength 
• Dynamic range 
lower than 
Fluo3/4/8 
• Kinetics slower 
than Fluo3/4/8 
 
[108] 
GECOs 
and 
RCamPs 
• Red-shifted  
• Genetically encoded 
• Can be targeted to cell 
compartments 
• Conditional expression is 
possible in e.g. beta or 
alpha cells 
 
• Requires viral 
vectors or mouse 
genetics for 
expression 
• Single wavelength 
• Dynamic range 
lower than 
GCamPs and 
Fluo3/4/8 
• Kinetics slower 
than Fluo3/4/8 
• Early versions 
localise to the 
nucleus 
 
 [109] 
Aequorins • Bioluminescent 
• Minimal phototoxicty as 
excitation not required 
• Genetically encoded 
• Can be targeted to cell 
compartments 
• Large dynamic range 
• Quantitative 
 
• Requires viral 
vectors . 
• Requires 
continuous addition 
of the substrate 
coelenterazine. 
• Requires 
specialised imaging 
setups 
[9] 
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FIGURE LEGENDS 
 
Figure 1: Systems controlling subcellular Ca2+ dynamics in the pancreatic islet beta cell. Glucose 
entry via Glut1 or Glut 2 leads to an increase of intracellular ATP/ADP ratio which closes KATP 
channels. The resulting decrease of membrane polarization allows the activation of voltage-dependent 
Ca2+ channels (VDCC). Acceleration of glucose metabolism stimulates the activity of plasma 
membrane Ca
2+
-ATPase (PMCA) and Sarco(endo-)plasmic reticulum Ca
2+
-ATPase (SERCA). The 
ER then serves as a Ca
2+ 
reservoir. Mitochondria take up Ca
2+
 through the Mitochondrial Calcium 
Uniporter (MCU) and release it by a Na+/Ca2+ exchanger (NCLX) or via the permeability transition 
pore (PTP) under conditions of metabolic stress. A plasma membrane Na+/Ca2+ exchanger is present 
at the  plasma membrane (NCX). SG, secretory granule, Lyso, lysosome. For further details see the 
text. 
 
Figure 2: Calcium regulation of mitochondrial metabolism. Pyruvate is transported into the 
mitochondria and is converted to acetyl-CoA by pyruvate dehydrogenase (PDH) which then enters the 
tricarboxylate (TCA) cycle. Calcium entry into mitochondria is facilitated by the mitochondrial 
calcium uniporter (MCU) which accelerates substrate movement through the TCA cycle via Ca
2+
-
dependant activation of isocitrate dehydrogenase (IDH) and α-ketoglutarate dehydrogenase (-KG). 
NADH drives respiratory chain complexes to generate a H+ gradient and hyperpolarisation of the 
mitochondrial membrane potential. H
+
 gradient dissipation subsequently stimulates ATP production 
by ATP synthase (complex V/F1Fo ATPase), the activity of which is also enhanced by Ca
2+
. ATP is 
transported out of the mitochondrial matrix via adenine nucleotide translocase (ANT) which is also 
stimulated by a rise in mitochondrial Ca
2+
. Key: aconitase (ACON), citrate synthase (CS), fumarase 
(FH), malate deydrogenase (MDH). 
 
Figure 3: Potential roles of sorcin in the pathogenesis of T2D. See the text and [61] for further 
details. 
Figure 4: Hubs and Followers. A) Hub cells (blue) direct the activity of follower cells (grey) via 
presently undefined mechanisms, leading to coordinated population behaviour and insulin release. B) 
Optical silencing of hubs using halorhodopsin (NpHR) leads to more stochastic population behaviour 
and impaired insulin secretion. C) Hubs are more energetic, more metabolic, less mature and less 
secretory than followers, and are vulnerable to insults (free fatty acid and cytokines). 
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